Secondary analysis of an RCT in 143 adults with insulin-treated type 2 diabetes using a GLP-1 RA: Control-IQ+ automated insulin delivery vs CGM alone lowered HbA1c by a mean 0.5% (95% CI -0.8 to -0.3), with no significant weight difference at 13 weeks.
Secondary analysisn = 143 adults
Graham et al. Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes